Energenesis Biomedical CO.,LTD. (6657.TW)

TWD 57.2

(-5.61%)

Inventory Summary of Energenesis Biomedical CO.,LTD.

  • Energenesis Biomedical CO.,LTD.'s latest annual inventory in 2023 was 733 Thousand TWD , up 31.83% from previous year.
  • Energenesis Biomedical CO.,LTD.'s latest quarterly inventory in 2024 Q2 was 585 Thousand TWD , down -5.2% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported annual inventory of 556 Thousand TWD in 2022, down -19.3% from previous year.
  • Energenesis Biomedical CO.,LTD. reported annual inventory of 689 Thousand TWD in 2021, down -3.23% from previous year.
  • Energenesis Biomedical CO.,LTD. reported quarterly inventory of 692 Thousand TWD for 2024 Q1, down -5.59% from previous quarter.
  • Energenesis Biomedical CO.,LTD. reported quarterly inventory of 599 Thousand TWD for 2023 Q3, down -18.06% from previous quarter.

Annual Inventory Chart of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Historical Annual Inventory of Energenesis Biomedical CO.,LTD. (2023 - 2019)

Year Inventory Inventory Growth
2023 733 Thousand TWD 31.83%
2022 556 Thousand TWD -19.3%
2021 689 Thousand TWD -3.23%
2020 712 Thousand TWD -23.11%
2019 926 Thousand TWD 0.0%

Peer Inventory Comparison of Energenesis Biomedical CO.,LTD.

Name Inventory Inventory Difference
Apex Biotechnology Corp. 747.71 Million TWD 99.902%
Sinphar Pharmaceutical Co.,Ltd. 839.19 Million TWD 99.913%
Panion & Bf Biotech Inc. 538.09 Million TWD 99.864%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 1.21 Billion TWD 99.939%
GenMont Biotech Incorporation 88.11 Million TWD 99.168%
Abnova (Taiwan) Corporation 408.3 Million TWD 99.82%
Adimmune Corporation 526.4 Million TWD 99.861%
Tanvex BioPharma, Inc. 108.28 Million TWD 99.323%
Polaris Group 36.35 Million TWD 97.984%
UnicoCell Biomed Co., Ltd. 5.45 Million TWD 86.553%
PELL Bio-Med Technology Co. Ltd. 3.76 Million TWD 80.521%